Ebola Vaccine Clinical Trials Ebola Vaccine RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
(Source: Trials)
Source: Trials - September 1, 2021 Category: Research Source Type: clinical trials

Prophylaxis Vaccine Antibodies Ebola
Condition:   Ebola Virus Disease Interventions:   Drug: ansuvimab;   Biological: Ervebo Sponsor:   ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2021 Category: Research Source Type: clinical trials

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
Conditions:   Ebola Virus Disease;   Marburg Virus Disease Interventions:   Biological: cAd3-Marburg;   Biological: cAd3-EBO-S Sponsors:   Albert B. Sabin Vaccine Institute;   ICON plc;   Oklahoma Blood Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2021 Category: Research Source Type: clinical trials